Abstract
The PRESERFLO MicroShunt (MicroShunt) is a novel glaucoma device to treat glaucoma. It is made from poly(styrene-block-isobutylene-block-styrene) (SIBS), which was the first elastomer developed primarily for long-term implant applications with the intention of minimizing the foreign body reaction. SIBS differs from conventional organic polymers in that it is composed of only carbon and hydrogen atoms without any heteroatoms, which play a role in the foreign body reaction. Furthermore, there are no cleavable groups on its backbone or side groups, and its nonsaturable backbone prevents the occurrence of embrittlement and cracking over time. Early work in pigs and rabbits confirmed its biocompatibility. SIBS has been used in the heart in over six million patients since 2000 and has been used in tens of thousands of eyes as a glaucoma shunt since 2006. This subchapter reviews the chemistry of SIBS, the design of the MicroShunt, and published safety and efficacy data from clinical studies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Handbook of Basic and Clinical Ocular Pharmacology and Therapeutics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.